N Cichanowitz

Affiliations

Merck & Co., Inc., Kenilworth, NJ, USA.

Publications (2)

Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28.

Journal of the European Academy of Dermatology and Venereology : JEADV

Avec: K A Papp , K Reich , A Blauvelt , A B Kimball , M Gooderham , S K Tyring , R Sinclair , D Thaci , Q Li , N Cichanowitz , S Green , C La Rosa

Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies.

The British journal of dermatology

Avec: A B Kimball , K A Papp , K Reich , M Gooderham , Q Li , N Cichanowitz , C La Rosa , A Blauvelt

Réseau de co-auteurs

K A Papp 2 collaborations

K Reich 2 collaborations

A Blauvelt 2 collaborations

A B Kimball 2 collaborations

M Gooderham 2 collaborations

Q Li 2 collaborations

C La Rosa 2 collaborations

S K Tyring 1 collaboration

R Sinclair 1 collaboration

D Thaci 1 collaboration

S Green 1 collaboration